Dianthus Therapeutics, Inc. (DNTH) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$76.07
Day's range
$84.86

Dianthus Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 8.20 M $799.33 M   5.56% 14.64%
BLACKROCK, INC. 08/07/2026 4.12 M $401.99 M   29.86% 7.36%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 3.89 M $379.05 M   200.92% 6.94%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 3.23 M $314.85 M   24.43% 5.76%
STATE STREET CORP 09/22/2026 2.36 M $229.80 M   68.52% 4.91%
FAIRMOUNT FUNDS MANAGEMENT LLC 08/14/2026 2.54 M $247.33 M   0.00% 4.53%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 2.51 M $245.16 M   119.27% 4.49%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.16 M $210.51 M   6.32% 3.85%
AVIDITY PARTNERS MANAGEMENT LP 08/14/2026 2.10 M $205.12 M   0.00% 3.76%
OCTAGON CAPITAL ADVISORS LP 08/14/2026 1.84 M $179.53 M   -5.39% 3.29%
TCG CROSSOVER MANAGEMENT, LLC 08/14/2026 1.68 M $163.44 M   0.00% 2.99%
FRED ALGER MANAGEMENT, LLC 08/14/2026 1.30 M $126.97 M   12.10% 2.32%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.26 M $122.70 M   37.36% 2.25%
VR ADVISER, LLC 08/14/2026 1.18 M $115.03 M   0.00% 2.11%
UBS GROUP AG 08/13/2026 1.14 M $111.15 M   45.95% 2.04%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 08/14/2026 1.13 M $109.70 M   10.35% 2.01%
JENNISON ASSOCIATES LLC 08/03/2026 1.02 M $99.60 M   110.61% 1.82%
POLAR CAPITAL HOLDINGS PLC 08/14/2026 1.02 M $99.31 M   -5.32% 1.82%
CITADEL ADVISORS LLC 09/02/2026 974.91 K $95.03 M   -39.46% 1.74%
FRANKLIN RESOURCES INC 08/13/2026 968.98 K $94.46 M   0.08% 1.73%
BAKER BROS. ADVISORS LP 08/14/2026 852.16 K $83.07 M   0.00% 1.52%
ALLIANCEBERNSTEIN L.P. 08/14/2026 834.15 K $70.00 M   -9.93% 1.49%
LOGOS GLOBAL MANAGEMENT LP 08/14/2026 800.00 K $77.98 M   100.00% 1.43%
CORMORANT ASSET MANAGEMENT, LP 08/14/2026 750.00 K $73.11 M   -21.05% 1.34%
BRAIDWELL LP 08/14/2026 594.56 K $57.96 M   -33.89% 1.06%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 570.12 K $55.57 M   63.18% 1.02%
AMERIPRISE FINANCIAL INC 08/14/2026 532.00 K $51.86 M   23.97% 0.95%
WOODLINE PARTNERS LP 08/14/2026 500.55 K $48.79 M   15.48% 0.89%
BARCLAYS PLC 08/14/2026 431.75 K $42.09 M   13.74% 0.77%
LORD, ABBETT & CO. LLC 08/14/2026 422.19 K $41.16 M   41.10% 0.75%
BIOIMPACT CAPITAL LLC 08/14/2026 420.00 K $40.94 M   -0.94% 0.75%
NORTHERN TRUST CORP 08/13/2026 411.79 K $40.14 M   35.57% 0.74%
AFFINITY ASSET ADVISORS, LLC 08/13/2026 400.00 K $38.99 M   14.29% 0.71%
SILVERARC CAPITAL MANAGEMENT, LLC 08/13/2026 390.00 K $38.02 M   -40.43% 0.70%
GOLDMAN SACHS GROUP INC 08/14/2026 382.16 K $37.25 M   -30.26% 0.68%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 365.96 K $35.67 M   19.82% 0.65%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 365.96 K $35.67 M   100.00% 0.65%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 08/14/2026 362.47 K $35.33 M   0.00% 0.65%
SPRUCE STREET CAPITAL LP 08/13/2026 354.82 K $34.59 M   -4.94% 0.63%
VIVO CAPITAL, LLC 08/14/2026 354.00 K $34.51 M   0.00% 0.63%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 321.50 K $31.33 M   -1.21% 0.57%
WESTFIELD CAPITAL MANAGEMENT CO LP 08/12/2026 314.91 K $30.70 M   100.00% 0.56%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 302.48 K $29.49 M   21.15% 0.54%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 295.27 K $28.78 M   -6.95% 0.53%
FIRST TURN MANAGEMENT, LLC 08/14/2026 285.77 K $27.86 M   29.35% 0.51%
ASSENAGON ASSET MANAGEMENT S.A. 08/21/2026 280.65 K $27.36 M   100.00% 0.50%
TANG CAPITAL MANAGEMENT LLC 08/14/2026 264.69 K $25.80 M   0.00% 0.47%
ARTISAN PARTNERS LIMITED PARTNERSHIP 08/13/2026 258.27 K $25.18 M   -32.41% 0.46%
BANK OF AMERICA CORP /DE/ 08/14/2026 256.83 K $25.04 M   36.05% 0.46%
BANK OF NEW YORK MELLON CORP 08/06/2026 256.39 K $24.99 M   36.08% 0.46%

Dianthus Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 319 institutional investors and hedge funds held shares of Dianthus Therapeutics Inc. The most heavily invested institutionals were:

EASTERN BANK: 10

Versant Capital Management, Inc: 6

MASSMUTUAL TRUST CO FSB/ADV: 0

FMR LLC: 8.2 M

BlackRock, Inc.: 4.12 M

T. Rowe Price Investment Management, Inc.: 3.89 M

137.66% of Dianthus Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 70.12 M shares in the last 24 months. This purchase volume represents approximately $5.56 B in transactions.